Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

HYPAQUE SODIUM 50% - LIQ IV DIN 02180650

Status: Cancelled Post Market
Holder: NYCOMED IMAGING A.S.
Molecule: DIATRIZOATE SODIUM

Health Canada record

Active ingredient(s)DIATRIZOATE SODIUM 50 %
Dosage formLiquid
RouteIntravenous
ScheduleETHICAL
ClassHuman
ATCV08AA01 DIATRIZOIC ACID
Original market date22-Apr-1998
Current status date03-Apr-2000
SourceHealth Canada DPD

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing DIATRIZOATE SODIUM

DINProductCompanyFormStrengthStatus
02180626HYPAQUE ORAL LIQUID - 50G/120MLNYCOMED IMAGING A.S.LiquidDIATRIZOATE SODIUM 50 GCancelled Post Market
02026902HYPAQUE ORAL LIQUID 50GM/120MLSANOFI CANADA, INC.LiquidDIATRIZOATE SODIUM 50 GCancelled Post Market
02180685HYPAQUE ORAL POWDERGE HEALTHCARE CANADA INCPowderDIATRIZOATE SODIUM 997.4 MGCancelled Post Market
02026988HYPAQUE ORAL POWDER 0.9974G/GSANOFI CANADA, INC.PowderDIATRIZOATE SODIUM 997.4 MGCancelled Post Market
01905007HYPAQUE PWR 100%STERLING WINTHROP INC.PowderDIATRIZOATE SODIUM 100 %Cancelled Post Market
01902768HYPAQUE SODIUM 50% LIQSTERLING WINTHROP INC.LiquidDIATRIZOATE SODIUM 50 %Cancelled Post Market
02017784HYPAQUE SODIUM LIQ 50%SANOFI CANADA, INC.LiquidDIATRIZOATE SODIUM 50 %Cancelled Post Market
02180677HYPAQUE-M 76%AMERSHAM HEALTH INCSolutionDIATRIZOATE SODIUM 10 %; DIATRIZOATE MEGLUMINE 66 %Cancelled Post Market

International API supply for DIATRIZOATE SODIUM

3 active FDA Drug Master Files.

Request a quote for HYPAQUE SODIUM 50% - LIQ IV

How to read a Canadian DIN record